Home » Newsletters » BioWorld

BioWorld

Dec. 12, 1991

View Archived Issues

LIPOSOME CO. DELAYS PHASE III TRIALS

1 MILLION TSI SHARES CONVERTIBLE

STOCKBROKER SUES ALPHA 1

BTGC LICENSES OPHTHALMIC IN ITALY

ROCHE, PERKIN-ELMER FORM ALLIANCE

PEGNOLOGY TO BE TESTED WITH AIDS DRUG

THREE COMPANIES COMPLETE OFFERINGS

NICOTINE PATCH BLOCKS SNUFFED

IDEC LICENSES MAbs TO FIGHT TUMORS

IMPROVED MOUSE MODEL OF ALZHEIMER'S

ENZO OFFERS NOTE CONVERSION PLAN

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for August 7, 2025.
Xtalpi finalizes $6B AI drug discovery deal with Dovetree
BioWorld
Quantumpharm Inc., known as Xtalpi Inc., announced receiving $51 million up front from a potential $5.99 billion deal with Dovetree LLC on Aug. 6. The...
Eyes on the prize: FDA approves Lenz’s drops for presbyopia
BioWorld
With the U.S. FDA’s approval of Lenz Therapeutics Inc.’s Vizz (aceclidine ophthalmic solution), there is a third eye drop on the market for treating presbyopia....
Lithium could change Alzheimer's care, but not all forms work
BioWorld Science
The difference between the origin of Alzheimer's disease (AD) and its symptoms is an obstacle to finding effective treatments. Scientists focused on amyloid-β...